TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,841,000 | -79.6% | 38,605 | -71.6% | 0.19% | -64.9% |
| Q3 2021 | $9,028,000 | -14.9% | 135,900 | 0.0% | 0.55% | +24.0% |
| Q2 2021 | $10,603,000 | -17.5% | 135,900 | 0.0% | 0.44% | -17.9% |
| Q1 2021 | $12,855,000 | +51.1% | 135,900 | +94.7% | 0.54% | +18.5% |
| Q4 2020 | $8,505,000 | -17.5% | 69,800 | -40.8% | 0.45% | -34.8% |
| Q3 2020 | $10,308,000 | +35.2% | 118,000 | 0.0% | 0.70% | +17.4% |
| Q2 2020 | $7,622,000 | +44.6% | 118,000 | 0.0% | 0.59% | +74.6% |
| Q1 2020 | $5,270,000 | -28.3% | 118,000 | 0.0% | 0.34% | -3.4% |
| Q4 2019 | $7,350,000 | +65.7% | 118,000 | 0.0% | 0.35% | +77.3% |
| Q3 2019 | $4,437,000 | – | 118,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |